Ilyang, Nutra to join forces in new drug R&D

Published: 2009-01-02 06:57:00

Updated: 2009-01-02 06:57:00

Ilyang Pharm and Nutra R&BT Inc., a local biopharmaceutical company, have agreed to join hands to develop new for treatment of arthritis, stroke and atopic disease, including antioxidants so that they can stay competitive with multinational drug manufacturers.

“The two companies said they would jointly support the research and development (R&D) program to acquire technologies needed to produ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.